Stem
STEM
NYSE
IPO2021
about STEM
Stem specializes in developing cutting-edge stem cell-based therapies and innovative solutions aimed at advancing medical treatments in regenerative medicine.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $18.97 | $19.06 | $17.75 | $156.65M | 179.82K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$2.84 | n/a | 4.01 | -33.61% | -62.22% | 0% |
